Endosome escape strategies for improving the efficacy of oligonucleotide delivery systems

Current Medicinal Chemistry

Volumn 22, Issue 29, 2015, Pages 3326-3346

  Wan, Y ^a   Moyle, P M ^a   Toth, I ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Endosome escape; Fusogenic peptides; Gene delivery; Non viral vectors; Oligonucleotides; Peptides

Indexed keywords

BACTERIAL TOXIN; CHEMICAL AGENT; CHOLESTEROL DERIVATIVE; CHOLESTERYL; DIMER; LIPID; OLIGONUCLEOTIDE; PEPTIDE; POLYMER; PROTEIN; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ARTICLE; ARYLATION; CHEMICAL MODIFICATION; CONJUGATION; DISULFIDE BOND; DRUG DELIVERY SYSTEM; ENDOSOME; PROTEIN MODIFICATION; STEARYLATION; ANIMAL; CHEMISTRY; GENE THERAPY; GENE TRANSFER; GENETICS; HUMAN; METABOLISM;

ANIMALS; ENDOSOMES; GENE TRANSFER TECHNIQUES; GENETIC THERAPY; HUMANS; OLIGONUCLEOTIDES; PEPTIDES;

EID: 84945267260     PISSN: 09298673     EISSN: 1875533X     Source Type: Journal    
DOI: 10.2174/0929867322666150825162941     Document Type: Article

References (132)

1. Ginn, S.L.; Alexander, I.E.; Edelstein, M.L.; Abedi, M.R.; Wixon, J. Gene therapy clinical trials worldwide to 2012-an update. J. Gene Med., 2013, 15(2), 65-77.
2. Sheridan, C. Gene therapy finds its niche. Nat. Biotechnol., 2011, 29(2), 121-128.
3. Byrne, B.J. Pathway for approval of a gene therapy orphan product: treading new ground. Mol. Ther., 2013, 21(8), 1465-1466.
4. Liang, W.; Lam, J.K.W. Endosomal Escape Pathways for Non-Viral Nucleic Acid Delivery Systems, Biochemistry Genetic and Molecular Biology: InTech, 2012.
5. Kay, M.A.; Glorioso, J.C.; Naldini, L. Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeutics. Nat. Med., 2001, 7(1), 33-40.
6. Verma, I.M.; Somia, N. Gene therapy - promises, problems and prospects. Nature, 1997, 389(6648), 239-242.
7. Elsabahy, M.; Nazarali, A.; Foldvari, M. Non-viral nucleic acid delivery: key challenges and future directions. Curr. Drug Deliv., 2011, 8(3), 235-244.
8. Mintzer, M.A.; Simanek, E.E. Nonviral vectors for gene delivery. Chem. Rev., 2009, 109(2), 259-302.
9. Zhang, Y.; Satterlee, A.; Huang, L. In vivo gene delivery by nonviral vectors: overcoming hurdles? Mol. Ther., 2012, 20(7), 1298-1304.
10. Geary, R.S. Antisense oligonucleotide pharmacokinetics and metabolism. Expert Opin. Drug Metab. Toxicol., 2009, 5(4), 381-391.
11. Dominska, M.; Dykxhoorn, D.M. Breaking down the barriers: siRNA delivery and endosome escape. J. Cell Sci., 2010, 123(8), 1183-1189.
12. Xiang, S.; Tong, H.; Shi, Q.; Fernandes, J.C.; Jin, T.; Dai, K.; Zhang, X. Uptake mechanisms of non-viral gene delivery. J. Control Release, 2012, 158(3), 371-378.
13. Miyata, K.; Nishiyama, N.; Kataoka, K. Rational design of smart supramolecular assemblies for gene delivery: chemical challenges in the creation of artificial viruses. Chem. Soc. Rev., 2012, 41(7), 2562-2574.
14. Varkouhi, A.K.; Scholte, M.; Storm, G.; Haisma, H.J. Endosomal escape pathways for delivery of biologicals. J. Control. Release, 2011, 151(3), 220-228.
15. Akinc, A.; Thomas, M.; Klibanov, A.M.; Langer, R. Exploring polyethylenimine-mediated DNA transfection and the proton sponge hypothesis. J. Gene. Med., 2005, 7, (5), 657-663.
16. Klemm, A.R.; Young, D.; Lloyd, J.B. Effects of polyethyl-eneimine on endocytosis and lysosome stability. Biochem. Pharmacol., 1998, 56(1), 41-46.
17. Boussif, O.; Lezoualch, F.; Zanta, M.A.; Mergny, M.D.; Scherman, D.; Demeneix, B.; Behr, J.P. A versatile vector for gene and oligonucleotide transfer into cells in culture and in-vivo - polyethylenimine. Proc. Natl. Acad. Sci. USA, 1995, 92(16), 7297-7301.
18. Grayson, A.C.; Doody, A.M.; Putnam, D. Biophysical and structural characterization of polyethylenimine-mediated siRNA delivery in vitro. Pharm. Res., 2006, 23(8), 1868-1876.
19. Creusat, G.; Rinaldi, A.S.; Weiss, E.; Elbaghdadi, R.; Remy, J.S.; Mulherkar, R.; Zuber, G. Proton sponge trick for pH-sensitive disassembly of polyethylenimine-based siRNA delivery systems. Bioconjug. Chem., 2010, 21(5), 994-1002.
20. Patnaik, S.; Gupta, K.C. Novel polyethylenimine-derived nanoparticles for in vivo gene delivery. Expert Opin. Drug Deliv., 2013, 10(2), 215-228.
21. Lv, H.; Zhang, S.; Wang, B.; Cui, S.; Yan, J. Toxicity of cationic lipids and cationic polymers in gene delivery. J. Control. Release, 2006, 114(1), 100-109.
22. Fischer, D.; Bieber, T.; Li, Y.; Elsasser, H.P.; Kissel, T. A novel non-viral vector for DNA delivery based on low molecular weight, branched polyethylenimine: effect of molecular weight on transfection efficiency and cytotoxicity. Pharm. Res., 1999, 16(8), 1273-1279.
23. Sun, Y.; Jiao, Y.; Wang, Y.; Lu, D.; Yang, W. The strategy to improve gene transfection efficiency and biocompatibility of hyperbranched PAMAM with the cooperation of PE-Gylated hyperbranched PAMAM. Int. J. Pharm., 2014, 465(1-2), 112-119.
24. Yu, G.S.; Bae, Y.M.; Choi, H.; Kong, B.; Choi, I.S.; Choi, J.S. Synthesis of PAMAM dendrimer derivatives with enhanced buffering capacity and remarkable gene transfection efficiency. Bioconjug. Chem., 2011, 22(6), 1046-1055.
25. Mukherjee, S.P.; Lyng, F.M.; Garcia, A.; Davoren, M.; Byrne, H.J. Mechanistic studies of in vitro cytotoxicity of poly(amidoamine) dendrimers in mammalian cells. Toxicol. Appl. Pharmacol., 2010, 248(3), 259-268.
26. Lynn, D.M.; Langer, R. Degradable poly(beta-amino esters): Synthesis, characterization, and self-assembly with plasmid DNA. J. Am. Chem. Soc, 2000, 122(44), 10761-10768.
27. Green, J.J.; Langer, R.; Anderson, D.G. A combinatorial polymer library approach yields insight into nonviral gene delivery. Acc. Chem. Res., 2008, 41(6), 749-759.
28. Murthy, N.; Robichaud, J.R.; Tirrell, D.A.; Stayton, P.S.; Hoffman, A.S. The design and synthesis of polymers for eukaryotic membrane disruption. J. Control. Release, 1999, 61(1-2), 137-143.
29. Jones, R.A.; Cheung, C.Y.; Black, F.E.; Zia, J.K.; Stayton, P.S.; Hoffman, A.S.; Wilson, M.R. Poly(2-alkylacrylic acid) polymers deliver molecules to the cytosol by pH-sensitive disruption of endosomal vesicles. Biochem. J., 2003, 372(Pt 1), 65-75.
30. Cheung, C.Y.; Murthy, N.; Stayton, P.S.; Hoffman, A.S. A pH-sensitive polymer that enhances cationic lipid-mediated gene transfer. Bioconjug. Chem., 2001, 12(6), 906-910.
31. Kyriakides, T.R.; Cheung, C.Y.; Murthy, N.; Bornstein, P.; Stayton, P.S.; Hoffman, A.S. pH-sensitive polymers that enhance intracellular drug delivery in vivo. J. Control. Release, 2002, 78(1-3), 295-303.
32. Mudhakir, D.; Harashima, H. Learning from the viral journey: how to enter cells and how to overcome intracellular barriers to reach the nucleus. Aaps J., 2009, 11(1), 65-77.
33. Hamilton, B.S.; Whittaker, G.R.; Daniel, S. Influenza virus-mediated membrane fusion: determinants of hemagglutinin fusogenic activity and experimental approaches for assessing virus fusion. Viruses, 2012, 4(7), 1144-1168.
34. Hughson, F.M. Structural characterization of viral fusion proteins. Curr. Biol., 1995, 5(3), 265-274.
35. Kalani, M.R.; Moradi, A.; Moradi, M.; Tajkhorshid, E. Characterizing a histidine switch controlling pH-dependent conformational changes of the influenza virus hemagglutinin. Biophys. J., 2013, 105(4), 993-1003.
36. Liou, J.S.; Liu, B.R.; Martin, A.L.; Huang, Y.W.; Chiang, HJ.; Lee, H.J. Protein transduction in human cells is enhanced by cell-penetrating peptides fused with an endoso-molytic HA2 sequence. Peptides, 2012, 37(2), 273-284.
37. Kwon, E.J.; Bergen, J.M.; Pun, S.H. Application of an HIV gp41-derived peptide for enhanced intracellular trafficking of synthetic gene and siRNA delivery vehicles. Bioconjug. Chem., 2008, 19(4), 920-927.
38. Costin, J.M.; Rausch, J.M.; Garry, R.F.; Wimley, W.C. Viroporin potential of the lentivirus lytic peptide (LLP) domains of the HIV-1 gp41 protein. Virol. J., 2007, 4, 123.
39. Srinivas, S.K.; Srinivas, R.V.; Anantharamaiah, G.M.; Segrest, J.P.; Compans, R.W. Membrane interactions of synthetic peptides corresponding to amphipathic helical segments of the human immunodeficiency virus type-1 envelope glycoprotein. J. Biol. Chem., 1992, 267(10), 7121-7127.
40. Tu, Y.; Kim, J.S. A fusogenic segment of glycoprotein H from herpes simplex virus enhances transfection efficiency of cationic liposomes. J. Gene Med., 2008, 10(6), 646-654.
41. Galdiero, S.; Falanga, A.; Vitiello, M.; Raiola, L.; Fattorusso, R.; Browne, H.; Pedone, C; Isernia, C; Galdiero, M. Analysis of a membrane interacting region of herpes simplex virus type 1 glycoprotein H. J. Biol. Chem., 2008, 283(44), 29993-30009.
42. Galdiero, S.; Falanga, A.; Vitiello, M.; Browne, H.; Pedone, C; Galdiero, M. Fusogenic domains in herpes simplex virus type 1 glycoprotein H. J. Biol. Chem., 2005, 280(31), 28632-28643.
43. Kamper, N.; Day, P.M.; Nowak, T.; Selinka, H.C.; Florin, L.; Bolscher, J.; Hilbig, L.; Schiller, J.T.; Sapp, M. A membrane-destabilizing peptide in capsid protein L2 is required for egress of papillomavirus genomes from endosomes. J. Virol., 2006, 80(2), 759-768.
44. Schnupf, P.; Portnoy, D.A. Listeriolysin O: a phagosome-specific lysin. Microbes Infect., 2007, 9(10), 1176-1187.
45. Beauregard, K.E.; Lee, K.D.; Collier, R.J.; Swanson, J.A. pH-dependent perforation of macrophage phagosomes by listeriolysin O from Listeria monocytogenes. J. Exp. Med., 1997, 186(7), 1159-1163.
46. Saito, G.; Amidon, G.L.; Lee, K.D. Enhanced cytosolic delivery of plasmid DNA by a sulfhydryl-activatable listeriolysin O/protamine conjugate utilizing cellular reducing potential. Gene Ther., 2003, 10(1), 72-83.
47. Kullberg, M.; Owens, J.L.; Mann, K. Listeriolysin O enhances cytoplasmic delivery by Her-2 targeting liposomes. J. Drug Target, 2010, 18(4), 313-320.
48. Lorenzi, G.L.; Lee, K.D. Enhanced plasmid DNA delivery using anionic LPDII by listeriolysin O incorporation. J. Gene Med., 2005, 7(8), 1077-1085.
49. Kullberg, M.; McCarthy, R.; Anchordoquy, T.J. Gene delivery to Her-2+ breast cancer cells using a two-component delivery system to achieve specificity. Nanomedicine, 2014, 10(6), 1253-62.
50. Choe, S.; Bennett, M.J.; Fujii, G.; Curmi, P.M.; Kantardjieff, K.A.; Collier, R.J.; Eisenberg, D. The crystal structure of diphtheria toxin. Nature, 1992, 357(6375), 216-222.
51. Kurnikov, I.V.; Kyrychenko, A.; Flores-Canales, J.C.; Rodnin, M.V.; Simakov, N.; Vargas-Uribe, M.; Posokhov, Y.O.; Kurnikova, M.; Ladokhin, A.S. pH-triggered conformational switching of the diphtheria toxin T-domain: the roles of N-terminal histidines. J. Mol. Biol, 2013, 425(15), 2752-2764.
52. Kakimoto, S.; Hamada, T.; Komatsu, Y.; Takagi, M.; Tanabe, T.; Azuma, H.; Shinkai, S.; Nagasaki, T. The conjugation of diphtheria toxin T domain to poly(ethylenimine) based vectors for enhanced endosomal escape during gene transfection. Biomaterials, 2009, 30(3), 402-408.
53. Kakimoto, S.; Tanabe, T.; Azuma, H.; Nagasaki, T. Enhanced internalization and endosomal escape of dualfunctionalized poly(ethyleneimine)s polyplex with diphtheria toxin T and R domains. Biomed. Pharmacother., 2010, 64(4), 296-301.
54. Tweten, R.K. Cholesterol-dependent cytolysins, a family of versatile pore-forming toxins. Infect. Immun., 2005, 73(10), 6199-6209.
55. Rasper, D.M.; Merrill, A.R. Evidence for the modulation of Pseudomonas aeruginosa exotoxin A-induced pore formation by membrane surface charge density. Biochemistry, 1994, 33(44), 12981-12989.
56. Esbjorner, E.K.; Oglecka, K.; Lincoln, P.; Graslund, A.; Norden, B. Membrane binding of pH-sensitive influenza fusion peptides. positioning, configuration, and induced leakage in a lipid vesicle model. Biochemistry, 2007, 46(47), 13490-13504.
57. El-Sayed, A.; Masuda, T.; Khalil, I.; Akita, H.; Harashima, H. Enhanced gene expression by a novel stearylated INF7 peptide derivative through fusion independent endosomal escape. J. Control. Release, 2009, 138(2), 160-167.
58. Luten, J.; van Steenbergen, M.J.; Lok, M.C.; de Graaff, A.M.; van Nostrum, CF.; Talsma, H.; Hennink, W.E. De-gradable PEG-folate coated poly(DMAEA-co-BA)phosphazene-based polyplexes exhibit receptor-specific gene expression. Eur. J. Pharm. Sci., 2008, 33(3), 241-251.
59. Lin, N.; Zheng, W.; Li, L.; Liu, H.; Wang, T.; Wang, P.; Ma, X. A novel system enhancing the endosomal escapes of peptides promotes Bak BH3 peptide inducing apoptosis in lung cancer A549 cells. Target Oncol., 2014, 9(2), 163-170.
60. Parente, R.A.; Nir, S.; Szoka, F.C., Jr. pH-dependent fusion of phosphatidylcholine small vesicles. Induction by a synthetic amphipathic peptide. J. Biol. Chem., 1988, 263(10), 4724-4730.
61. Li, W.; Nicol, F.; Szoka, F.C., Jr. GALA: a designed synthetic pH-responsive amphipathic peptide with applications in drug and gene delivery. Adv. Drug Deliv. Rev., 2004, 56(7), 967-985.
62. Parente, R.A.; Nir, S.; Szoka, F.C., Jr. Mechanism of leakage of phospholipid vesicle contents induced by the peptide GALA. Biochemistry, 1990, 29(37), 8720-8728.
63. Hatakeyama, H.; Ito, E.; Akita, H.; Oishi, M.; Nagasaki, Y.; Futaki, S.; Harashima, H. A pH-sensitive fusogenic peptide facilitates endosomal escape and greatly enhances the gene silencing of siRNA-containing nanoparticles in vitro and in vivo. J. Control. Release, 2009, 139(2), 127-132.
64. Sakurai, Y.; Hatakeyama, H.; Sato, Y.; Akita, H.; Takayama, K.; Kobayashi, S.; Futaki, S.; Harashima, H. Endosomal escape and the knockdown efficiency of liposo-mal-siRNA by the fusogenic peptide shGALA. Biomaterials, 2011, 32(24), 5733-5742.
65. Akita, H.; Masuda, T.; Nishio, T.; Niikura, K.; Ijiro, K.; Harashima, H. Improving in vivo hepatic transfection activity by controlling intracellular trafficking: the function of GALA and maltotriose. Mol. Pharm., 2011, 8(4), 1436-1442.
66. Kakudo, T.; Chaki, S.; Futaki, S.; Nakase, I.; Akaji, K.; Kawakami, T.; Maruyama, K.; Kamiya, H.; Harashima, H. Transferrin-modified liposomes equipped with a pH-sensitive fusogenic peptide: an artificial viral-like delivery system. Biochemistry, 2004, 43(19), 5618-5628.
67. Sasaki, K.; Kogure, K.; Chaki, S.; Nakamura, Y.; Moriguchi, R.; Hamada, H.; Danev, R.; Nagayama, K.; Futaki, S.; Harashima, H. An artificial virus-like nano carrier system: enhanced endosomal escape of nanoparticles via synergistic action of pH-sensitive fusogenic peptide derivatives. Anal. Bioanal. Chem., 2008, 391(8), 2717-2727.
68. Kusumoto, K.; Akita, H.; Ishitsuka, T.; Matsumoto, Y.; Nomoto, T.; Furukawa, R.; El-Sayed, A.; Hatakeyama, H.; Kajimoto, K.; Yamada, Y.; Kataoka, K.; Harashima, H. Lipid envelope-type nanoparticle incorporating a multifunctional peptide for systemic siRNA delivery to the pulmonary endothelium. ACS Nano, 2013, 7(9), 7534-7541.
69. Wyman, T.B.; Nicol, F.; Zelphati, O.; Scaria, P.V.; Plank, C; Szoka, F.C., Jr. Design, synthesis, and characterization of a cationic peptide that binds to nucleic acids and perme-abilizes bilayers. Biochemistry, 1997, 36(10), 3008-3017.
70. Cho, Y.W.; Kim, J.D.; Park, K. Polycation gene delivery systems: escape from endosomes to cytosol. J. Pharm. Pharmacol., 2003, 55(6), 721-734.
71. Min, S.H.; Lee, D.C.; Lim, M.J.; Park, H.S.; Kim, D.M.; Cho, C.W.; Yoon do, Y.; Yeom, Y.I. A composite gene delivery system consisting of polyethylenimine and an amphipathic peptide KALA. J. Gene Med., 2006, 8(12), 1425-1434.
72. Midoux, P.; Kichler, A.; Boutin, V.; Maurizot, J.C.; Monsigny, M. Membrane permeabilization and efficient gene transfer by a peptide containing several histidines. Bioconjug. Chem., 1998, 9(2), 260-267.
73. Bure, C; Maget, R.; Delmas, A.F.; Pichon, C; Midoux, P. Histidine-rich peptide: evidence for a single zinc-binding site on H5WYG peptide that promotes membrane fusion at neutral pH. J. Mass Spectrom., 2009, 44(1), 81-89.
74. Sadeghian, F.; Hosseinkhani, S.; Alizadeh, A.; Hatefi, A. Design, engineering and preparation of a multi-domain fusion vector for gene delivery. Int. J Pharm., 2012, 427(2), 393-399.
75. Canine, B.F.; Wang, Y.; Hatefi, A. Biosynthesis and characterization of a novel genetically engineered polymer for targeted gene transfer to cancer cells. J. Control. Release, 2009, 138(3), 188-196.
76. Moore, N.M.; Sheppard, C.L.; Barbour, T.R.; Sakiyama-Elbert, S.E. The effect of endosomal escape peptides on in vitro gene delivery of polyethylene gly col-based vehicles. J. Gene Med., 2008, 10(10), 1134-1149.
77. Kichler, A.; Leborgne, C; Marz, J.; Danos, O.; Bechinger, B. Histidine-rich amphipathic peptide antibiotics promote efficient delivery of DNA into mammalian cells. Proc. Natl. Acad. Sci. USA, 2003, 100(4), 1564-1568.
78. Marquette, A.; Mason, A.J.; Bechinger, B. Aggregation and membrane permeabilizing properties of designed histidine-containing cationic linear peptide antibiotics. J. Pept. Sci., 2008, 14(4), 488-495.
79. Langlet-Bertin, B.; Leborgne, C; Scherman, D.; Bechinger, B.; Mason, A.J.; Kichler, A. Design and evaluation of histidine-rich amphipathic peptides for siRNA delivery. Pharm. Res., 2010, 27(7), 1426-1436.
80. Kichler, A.; Leborgne, C; Danos, O.; Bechinger, B. Characterization of the gene transfer process mediated by histidine-rich peptides. J. Mol. Med. (Berl), 2007, 85(2), 191-201.
81. Lo, S.L.; Wang, S. An endosomolytic Tat peptide produced by incorporation of histidine and cysteine residues as a nonviral vector for DNA transfection. Biomaterials, 2008, 29(15), 2408-2414.
82. Asayama, S.; Hamaya, A.; Sekine, T.; Kawakami, H.; Nagaoka, S. Aminated poly(L-histidine) as new pH-sensitive DNA carrier. Nucleic Acids Symp. Ser (Oxf), 2004, (48), 229-230.
83. Midoux, P.; Monsigny, M. Efficient gene transfer by histi-dylated polylysine/pDNA complexes. Bioconjug. Chem., 1999, 10(3), 406-411.
84. Summerton, J.E. Endo-Porter: a novel reagent for safe, effective delivery of substances into cells. Ann. N Y Acad. Sci., 2005, 1058, 62-75.
85. Bartz, R.; Fan, H.H.; Zhang, J.T.; Innocent, N.; Cherrin, C; Beck, S.C.; Pei, Y.; Momose, A.; Jadhav, V.; Tellers, D.M.; Meng, F.Y.; Crocker, L.S.; Sepp-Lorenzino, L.; Barnett, S.F. Effective siRNA delivery and target mRNA degradation using an amphipathic peptide to facilitate pH-dependent endosomal escape. Biochemical. J., 2011, 435, 475-487.
86. Summerton, J.E. Weak-base amphiphilic delivery peptides for delivering large polar substances via indirect endocyto-sis-mediated delivery; predominantly non-ionic at neutral pH, bind but do not permeabilize cell membranes until after endocytosis and acidification, 2006.
87. Gottschalk, S.; Sparrow, J.T.; Hauer, J.; Mims, M.P.; Leland, F.E.; Woo, S.L.; Smith, L.C. A novel DNA-peptide complex for efficient gene transfer and expression in mammalian cells. Gene Ther., 1996, 3(5), 448-457.
88. Rittner, K.; Benavente, A.; Bompard-Sorlet, A.; Heitz, F.; Divita, G.; Brasseur, R.; Jacobs, E. New basic membrane-destabilizing peptides for plasmid-based gene delivery in vitro and in vivo. Mol. Ther., 2002, 5(2), 104-114.
89. Plank, C; Oberhauser, B.; Mechtler, K.; Koch, C; Wagner, E. The influence of endosome-disruptive peptides on gene transfer using synthetic virus-like gene transfer systems. J. Biol. Chem., 1994, 269(17), 12918-12924.
90. Jaaskelainen, I.; Peltola, S.; Honkakoski, P.; Monkkonen, J.; Urtti, A. A lipid carrier with a membrane active component and a small complex size are required for efficient cellular delivery of anti-sense phosphorothioate oligonucleotides. Eur. J. Pharm. Sci., 2000, 10(3), 187-193.
91. Yang, L.; Harroun, T.A.; Weiss, T.M.; Ding, L.; Huang, H.W. Barrel-stave model or toroidal model? A case study on melittin pores. Biophys. J., 2001, 81(3), 1475-1485.
92. Ogris, M.; Carlisle, R.C.; Bettinger, T.; Seymour, L.W. Melittin enables efficient vesicular escape and enhanced nuclear access of nonviral gene delivery vectors. J. Biol. Chem., 2001, 276(50), 47550-47555.
93. Zhang, W.; Song, J.; Liang, R.; Zheng, X.; Chen, J.; Li, G.; Zhang, B.; Yan, X.; Wang, R. Stearylated antimicrobial peptide melittin and its retro isomer for efficient gene trans-fection. Bioconjug. Chem., 2013, 24(11), 1805-1812.
94. Schellinger, J.G.; Pahang, J.A.; Johnson, R.N.; Chu, D.S.; Sellers, D.L.; Maris, D.O.; Convertine, A.J.; Stayton, P.S.; Horner, P.J.; Pun, S.H. Melittin-grafted HPMA-oligolysine based copolymers for gene delivery. Biomaterials, 2013, 34(9), 2318-2326.
95. Mochizuki, S.; Kanegae, N.; Nishina, K.; Kamikawa, Y.; Koiwai, K.; Masunaga, H.; Sakurai, K. The role of the helper lipid dioleoylphosphatidylethanolamine (DOPE) for DNA transfection cooperating with a cationic lipid bearing ethylenediamine. Biochim. Biophys. Acta, 2013, 1828(2), 412-418.
96. Koshkaryev, A.; Piroyan, A.; Torchilin, V.P. Bleomycin in octaarginine-modified fusogenic liposomes results in improved tumor growth inhibition. Cancer Lett., 2013, 334(2), 293-301.
97. Akita, H.; Kudo, A.; Minoura, A.; Yamaguti, M.; Khalil, I.A.; Moriguchi, R.; Masuda, T.; Danev, R.; Nagayama, K.; Kogure, K.; Harashima, H. Multi-layered nanoparticles for penetrating the endosome and nuclear membrane via a stepwise membrane fusion process. Biomaterials, 2009, 30(15), 2940-2949.
98. Kanasty, R.; Dorkin, J.R.; Vegas, A.; Anderson, D. Delivery materials for siRNA therapeutics. Nat. Mater, 2013, 12(11), 967-977.
99. El-Sayed, A.; Futaki, S.; Harashima, H. Delivery of mac-romolecules using arginine-rich cell-penetrating peptides: ways to overcome endosomal entrapment. Aaps J., 2009, 11(1), 13-22.
100. Hafez, I.M.; Cullis, P.R. Roles of lipid polymorphism in intracellular delivery. Adv. Drug Deliv. Rev., 2001, 47(2-3), 139-148.
101. Prata, C.A.; Li, Y.; Luo, D.; McIntosh, T.J.; Barthelemy, P.; Grinstaff, M.W. A new helper phospholipid for gene delivery. Chem. Commun. (Camb), 2008, (13), 1566-1568.
102. LaManna, CM.; Lusic, H.; Camplo, M.; McIntosh, T.J.; Barthelemy, P.; Grinstaff, M.W. Charge-reversal lipids, peptide-based lipids, and nucleoside-based lipids for gene delivery. Acc. Chem. Res., 2012, 45(7), 1026-1038.
103. Khalil, I.A.; Kogure, K.; Akita, H.; Harashima, H. Uptake pathways and subsequent intracellular trafficking in nonviral gene delivery. Pharmacol. Rev., 2006, 58(1), 32-45.
104. Madani, F.; Lindberg, S.; Langel, U.; Futaki, S.; Graslund, A. Mechanisms of cellular uptake of cell-penetrating peptides. J. Biophys., 2011, 2011, 414729.
105. Andaloussi, S.E.; Lehto, T.; Mager, I.; Rosenthal-Aizman, K.; Oprea, II; Simonson, O.E.; Sork, H.; Ezzat, K.; Co-polovici, D.M.; Kurrikoff, K.; Viola, J.R.; Zaghloul, E.M.; Sillard, R.; Johansson, HJ.; Said Hassane, F.; Guterstam, P.; Suhorutsenko, J.; Moreno, P.M.; Oskolkov, N.; Halldin, J.; Tedebark, U.; Metspalu, A.; Lebleu, B.; Lehtio, J.; Smith, C.I.; Langel, U. Design of a peptide-based vector, PepFect6, for efficient delivery of siRNA in cell culture and systemically in vivo. Nucleic Acids Res., 2011, 39(9), 3972-3987.
106. Yu, H.; Zou, Y.; Wang, Y.; Huang, X.; Huang, G.; Sumer, B.D.; Boothman, D.A.; Gao, J. Overcoming endosomal barrier by amphotericin B-loaded dual pH-responsive PDMA-b-PDPA micelleplexes for siRNA delivery. ACS Nano, 2011, 5(11), 9246-9255.
107. Lehto, T.; Kurrikoff, K.; Langel, U. Cell-penetrating peptides for the delivery of nucleic acids. Expert Opin. Drug Deliv., 2012, 9(7), 823-836.
108. Margus, H.; Padari, K.; Pooga, M. Cell-penetrating peptides as versatile vehicles for oligonucleotide delivery. Mol. Ther, 2012, 20(3), 525-533.
109. Mae, M.; Andaloussi, S.E.; Lehto, T.; Langel, U. Chemically modified cell-penetrating peptides for the delivery of nucleic acids. Expert Opin. Drug Deliv., 2009, 6(11), 1195-1205.
110. El-Sayed, A.; Masuda, T.; Akita, H.; Harashima, H. Stearylated INF7 peptide enhances endosomal escape and gene expression of PEGylated nanoparticles both in vitro and in vivo. J. Pharm. Sci., 2012, 101(2), 879-882.
111. Shaheen, S.M.; Akita, H.; Nakamura, T.; Takayama, S.; Futaki, S.; Yamashita, A.; Katoono, R.; Yui, N.; Harashima, H. KALA-modified multi-layered nanoparticles as gene carriers for MHC class-I mediated antigen presentation for a DNA vaccine. Biomaterials, 2011, 32(26), 6342-6350.
112. Akita, H.; Kogure, K.; Moriguchi, R.; Nakamura, Y.; Higashi, T.; Nakamura, T.; Serada, S.; Fujimoto, M.; Naka, T.; Futaki, S.; Harashima, H. Nanoparticles for ex vivo siRNA delivery to dendritic cells for cancer vaccines: programmed endosomal escape and dissociation. J. Control. Release, 2010, 143(3), 311-317.
113. Qin, B.; Chen, Z.; Jin, W.; Cheng, K. Development of cho-lesteryl peptide micelles for siRNA delivery. J. Control. Release, 2013, 172(1), 159-168.
114. Mok, H.; Park, T.G. Self-crosslinked and reducible fusogenic peptides for intracellular delivery of siRNA. Bio-polymers, 2008, 89(10), 881-888.
115. Chen, C.P.; Kim, J.S.; Steenblock, E.; Liu, D.; Rice, K.G. Gene transfer with poly-melittin peptides. Bioconjug. Chem., 2006, 17(4), 1057-1062.
116. Takei, J.; Remenyi, A.; Clarke, A.R.; Dempsey, C.E. Self-association of disulfide-dimerized melittin analogues. Biochemistry, 1998, 37(16), 5699-5708.
117. Oliveira, S.; van Rooy, I.; Kranenburg, O.; Storm, G.; Schiffelers, R.M. Fusogenic peptides enhance endosomal escape improving siRNA-induced silencing of oncogenes. Int. J. Pharm., 2007, 331(2), 211-214.
118. Mastrobattista, E.; Koning, G.A.; van Bloois, L.; Filipe, A.C.; Jiskoot, W.; Storm, G. Functional characterization of an endosome-disruptive peptide and its application in cyto-solic delivery of immunoliposome-entrapped proteins. J. Biol. Chem., 2002, 277(30), 27135-27143.
119. Wadia, J.S.; Stan, R.V.; Dowdy, S.F. Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis. Nat. Med., 2004, 10(3), 310-315.
120. Min, S.H.; Kim, D.M.; Kim, M.N.; Ge, J.; Lee, D.C.; Park, I.Y.; Park, K.C.; Hwang, J.S.; Cho, C.W.; Yeom, Y.I., Gene delivery using a derivative of the protein transduction domain peptide, K-Antp. Biomaterials, 2010, 31, (7), 1858-1864.
121. Cantini, L.; Attaway, C.C.; Butler, B.; Andino, L.M.; Sokolosky, M.L.; Jakymiw, A. Fusogenic-oligoarginine peptide-mediated delivery of siRNAs targeting the CIP2A oncogene into oral cancer cells. PLoS One, 2013, 8(9), e73348.
122. Lee, H.; Jeong, J.H.; Park, T.G. A new gene delivery formulation of polyethylenimine/DNA complexes coated with PEG conjugated fusogenic peptide. J. Control. Release, 2001, 76(1-2), 183-192.
123. Lin, B.F.; Missirlis, D.; Krogstad, D.V.; Tirrell, M. Structural effects and lipid membrane interactions of the pH-responsive GALA peptide with fatty acid acylation. Biochemistry, 2012, 51(23), 4658-4668.
124. Puyal, C; Maurin, L.; Miquel, G.; Bienvenue, A.; Philippot, J. Design of a short membrane-destabilizing peptide cova-lently bound to liposomes. Biochim. Biophys. Acta, 1994, 1195(2), 259-266.
125. Meyer, M.; Zintchenko, A.; Ogris, M.; Wagner, E. A di-methylmaleic acid-melittin-polylysine conjugate with reduced toxicity, pH-triggered endosomolytic activity and enhanced gene transfer potential. J. Gene Med., 2007, 9(9), 797-805.
126. Meyer, M.; Philipp, A.; Oskuee, R.; Schmidt, C; Wagner, E. Breathing life into polycations: functionalization with pH-responsive endosomolytic peptides and polyethylene glycol enables siRNA delivery. J. Am. Chem. Soc, 2008, 130(11), 3272-3273.
127. Meyer, M.; Dohmen, C; Philipp, A.; Kiener, D.; Maiwald, G.; Scheu, C; Ogris, M.; Wagner, E. Synthesis and biological evaluation of a bioresponsive and endosomolytic siRNA-polymer conjugate. Mol. Pharm., 2009, 6(3), 752-762.
128. Tan, Y.X.; Chen, C; Wang, Y.L.; Lin, S.; Wang, Y.; Li, S.B.; Jin, X.P.; Gao, H.W.; Du, F.S.; Gong, F.; Ji, S.P. Truncated peptides from melittin and its analog with high lytic activity at endosomal pH enhance branched polyeth-ylenimine-mediated gene transfection. J. Gene Med., 2012, 14(4), 241-250.
129. Kwon, E.J.; Liong, S.; Pun, S.H. A truncated HGP peptide sequence that retains endosomolytic activity and improves gene delivery efficiencies. Mol. Pharm., 2010, 7(4), 1260-1265.
130. Galdiero, S.; Falanga, A.; Vitiello, M.; Raiola, L.; Russo, L.; Pedone, C; Isernia, C; Galdiero, M. The presence of a single N-terminal histidine residue enhances the fusogenic properties of a Membranotropic peptide derived from herpes simplex virus type 1 glycoprotein H. J. Biol. Chem., 2010, 285(22), 17123-17136.
131. Mann, A.; Shukla, V.; Khanduri, R.; Dabral, S.; Singh, H.; Ganguli, M. Linear short histidine and cysteine modified arginine peptides constitute a potential class of DNA delivery agents. Mol. Pharm., 2014, 11(3), 683-696.
132. Tanaka, K.; Kanazawa, T.; Ogawa, T.; Takashima, Y.; Fukuda, T.; Okada, H. Disulfide crosslinked stearoyl carrier peptides containing arginine and histidine enhance siRNA uptake and gene silencing. Int. J. Pharm., 2010, 398(1-2), 219-224.